Dysentery Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Alerts
• Clinical Trials

A Study to Determine If a New Shigella Vaccine is Safe, Induces Immunity and The Best Dose Among Kenyan Infants
Condition:   Shigellosis Interventions:   Biological: Shigella 4V;   Biological: MenACWY;   Biological: Rabies;   Biological: Diphtheria, Tetanus and Pertussis (DTaP);   Biological: Placebo Sponsors:   LimmaTech Biologics AG;   Kenya Medical Research Institute;   KEMRI-Wellcome Trust Collaborative Research Program Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2019 Category: Research Source Type: clinical trials